CN Patent

CN106279335A — 一种制备奥贝胆酸及其中间体的方法

Assigned to Qilu Pharmaceutical Co Ltd · Expires 2017-01-04 · 9y expired

What this patent protects

本发明属于医药化学技术领域，具体涉及一种制备药物奥贝胆酸及其中间体的新方法，其通过催化氢化化合物III得到中间体II进而制备奥贝胆酸，具有操作简便、反应条件温和的优点，降低反应温度，减少羟基脱水等副反应的发生，提高了收率，适合大规模生产。

USPTO Abstract

本发明属于医药化学技术领域，具体涉及一种制备药物奥贝胆酸及其中间体的新方法，其通过催化氢化化合物III得到中间体II进而制备奥贝胆酸，具有操作简便、反应条件温和的优点，降低反应温度，减少羟基脱水等副反应的发生，提高了收率，适合大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106279335A
Jurisdiction
CN
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Qilu Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.